产品标题 产品货号 产品规格 厂家
Human asparaginyl-tRNA synthetase (NARS) from ORIGENE TECHNOLOGIESTP30008720 ugORIGENE TECHNOLOGIES
Human asparaginyl-tRNA synthetase 2, mitochondrial (putative) (NARS2), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIESTP30320120 ugORIGENE TECHNOLOGIES
Human aspartate beta-hydroxylase (ASPH), transcript variant 1 from ORIGENE TECHNOLOGIESTP31679620 ugORIGENE TECHNOLOGIES
Human aspartate beta-hydroxylase (ASPH), transcript variant 2 from ORIGENE TECHNOLOGIESTP32393020 ugORIGENE TECHNOLOGIES
Human aspartate beta-hydroxylase (ASPH), transcript variant 3 from ORIGENE TECHNOLOGIESTP31181720 ugORIGENE TECHNOLOGIES
Human aspartate beta-hydroxylase (ASPH), transcript variant 10. from ORIGENE TECHNOLOGIESTP32823020 ugORIGENE TECHNOLOGIES
Human aspartate beta-hydroxylase (ASPH), transcript variant 11. from ORIGENE TECHNOLOGIESTP32820320 ugORIGENE TECHNOLOGIES
Human aspartate beta-hydroxylase domain containing 1 (ASPHD1) from ORIGENE TECHNOLOGIESTP31922620 ugORIGENE TECHNOLOGIES
Human aspartate beta-hydroxylase domain containing 2 (ASPHD2) from ORIGENE TECHNOLOGIESTP30749020 ugORIGENE TECHNOLOGIES
Human aspartate dehydrogenase domain containing (ASPDH), transcript variant 1 from ORIGENE TECHNOLOGIESTP32539020 ugORIGENE TECHNOLOGIES
Human aspartate dehydrogenase domain containing (ASPDH), transcript variant 2 from ORIGENE TECHNOLOGIESTP76023150 ugORIGENE TECHNOLOGIES
Human aspartate dehydrogenase domain containing (ASPDH), transcript variant 2, full length from ORIGENE TECHNOLOGIESTP76032750 ugORIGENE TECHNOLOGIES
Human RNA: Cecum; Adenocarcinoma of colon, metastatic from ORIGENE TECHNOLOGIESCR5619385 ugORIGENE TECHNOLOGIES
Human RNA: Cecum; Adenocarcinoma of colon, metastatic from ORIGENE TECHNOLOGIESCR5628095 ugORIGENE TECHNOLOGIES
Human RNA: Cecum; Adenocarcinoma of colon, mucinous from ORIGENE TECHNOLOGIESCR5596805 ugORIGENE TECHNOLOGIES
Human RNA: Cecum; Adenocarcinoma of colon, mucinous from ORIGENE TECHNOLOGIESCR5602635 ugORIGENE TECHNOLOGIES
Human RNA: Cecum; Adenoma of cecum from ORIGENE TECHNOLOGIESCR5591545 ugORIGENE TECHNOLOGIES
Human RNA: Cecum; Crohns disease from ORIGENE TECHNOLOGIESCR5602535 ugORIGENE TECHNOLOGIES
Human RNA: Cecum, normal from ORIGENE TECHNOLOGIESCR5593955 ugORIGENE TECHNOLOGIES
Human RNA: Cecum, normal from ORIGENE TECHNOLOGIESCR5594175 ugORIGENE TECHNOLOGIES
Human RNA: Cecum, normal from ORIGENE TECHNOLOGIESCR5594345 ugORIGENE TECHNOLOGIES
Human RNA: Cecum, normal from ORIGENE TECHNOLOGIESCR5610885 ugORIGENE TECHNOLOGIES
Human RNA: Cecum, normal from ORIGENE TECHNOLOGIESCR5610905 ugORIGENE TECHNOLOGIES
Human RNA: Cecum, normal from ORIGENE TECHNOLOGIESCR5620715 ugORIGENE TECHNOLOGIES
Human RNA: Cecum, normal from ORIGENE TECHNOLOGIESCR5625155 ugORIGENE TECHNOLOGIES
Human RNA: Cervix; Adenocarcinoma, metastatic, consistent with cervical primary from ORIGENE TECHNOLOGIESCR5611765 ugORIGENE TECHNOLOGIES
Human RNA: Cervix; Adenocarcinoma of cervix, endometrioid from ORIGENE TECHNOLOGIESCR5598555 ugORIGENE TECHNOLOGIES
Human RNA: Cervix; Adenocarcinoma of cervix, metastatic from ORIGENE TECHNOLOGIESCR5612195 ugORIGENE TECHNOLOGIES
Human RNA: Cervix; Carcinoma of cervix, adenosquamous from ORIGENE TECHNOLOGIESCR5602135 ugORIGENE TECHNOLOGIES
Human RNA: Cervix; Carcinoma of cervix, squamous cell from ORIGENE TECHNOLOGIESCR5613435 ugORIGENE TECHNOLOGIES
Human RNA: Cervix; Carcinoma of cervix, squamous cell from ORIGENE TECHNOLOGIESCR5615475 ugORIGENE TECHNOLOGIES
Human RNA: Cervix; Carcinoma of cervix, squamous cell from ORIGENE TECHNOLOGIESCR5623305 ugORIGENE TECHNOLOGIES
Human RNA: Cervix; Carcinoma of cervix, squamous cell, large cell, non-keratinizing from ORIGENE TECHNOLOGIESCR5612685 ugORIGENE TECHNOLOGIES
Human RNA: Cervix; Carcinoma of cervix, squamous cell, large cell, non-keratinizing from ORIGENE TECHNOLOGIESCR5629395 ugORIGENE TECHNOLOGIES
Human RNA: Cervix; Carcinoma of cervix, squamous cell, large cell, non-keratinizing from ORIGENE TECHNOLOGIESCR5593455 ugORIGENE TECHNOLOGIES
Human RNA: Cervix; Carcinoma of cervix, squamous cell, metastatic from ORIGENE TECHNOLOGIESCR5591625 ugORIGENE TECHNOLOGIES
Human RNA: Cervix; Leiomyosarcoma from ORIGENE TECHNOLOGIESCR5630295 ugORIGENE TECHNOLOGIES
Phosducin (PDC), transcript variant 2 from ORIGENE TECHNOLOGIESLY411611100 ugORIGENE TECHNOLOGIES
Phosphatase and actin regulator 1 (PHACTR1) from ORIGENE TECHNOLOGIESLY410643100 ugORIGENE TECHNOLOGIES
Phosphatase and actin regulator 2 (PHACTR2), transcript variant 1 from ORIGENE TECHNOLOGIESLY420232100 ugORIGENE TECHNOLOGIES
Phosphatase and actin regulator 2 (PHACTR2), transcript variant 3 from ORIGENE TECHNOLOGIESLY415095100 ugORIGENE TECHNOLOGIES
Phosphatase and actin regulator 4 (PHACTR4), transcript variant 1 from ORIGENE TECHNOLOGIESLY420773100 ugORIGENE TECHNOLOGIES
Phosphatase and actin regulator 4 (PHACTR4), transcript variant 2 from ORIGENE TECHNOLOGIESLY411450100 ugORIGENE TECHNOLOGIES
Phosphatase and tensin homolog (PTEN) from ORIGENE TECHNOLOGIESLY424803100 ugORIGENE TECHNOLOGIES
Phosphatase, orphan 2 (PHOSPHO2) from ORIGENE TECHNOLOGIESLY423436100 ugORIGENE TECHNOLOGIES
Phosphatase, orphan 1 (PHOSPHO1), transcript variant 1 from ORIGENE TECHNOLOGIESLY428350100 ugORIGENE TECHNOLOGIES
Phosphatase, orphan 1 (PHOSPHO1), transcript variant 2 from ORIGENE TECHNOLOGIESLY405893100 ugORIGENE TECHNOLOGIES
Phosphate cytidylyltransferase 1, choline, alpha (PCYT1A) from ORIGENE TECHNOLOGIESLY417575100 ugORIGENE TECHNOLOGIES
Phosphate cytidylyltransferase 1, choline, beta (PCYT1B), transcript variant 1 from ORIGENE TECHNOLOGIESLY417711100 ugORIGENE TECHNOLOGIES
Phosphate cytidylyltransferase 1, choline, beta (PCYT1B), transcript variant 2 from ORIGENE TECHNOLOGIESLY431865100 ugORIGENE TECHNOLOGIES
 |< < 2134 2135 2136 2137 2138 2139 2140 2141 2142 > >| 第 2136/6274 页